| Date |
Report No. |
Title |
| Date Feb. 9, 2007 |
Report No. GAO-07-481T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 10:00 a.m. EST Friday, February 9, 2007 Testimony Before the Committee on Oversight and Government Reform, House of Representatives PRESCRIPTION DRUGS Oversight of Drug Pricing in Federal Programs
Statement of John E. Dicken Director, Health Care GAO-07-481T February 9, 2007 PRESCRIPTION DRUGS Highlights
Highlig... |
| Date June 22, 2005 |
Report No. GAO-05-850T |
Title
United States Government Accountability Office GAO
For Release on Delivery Expected at 2:00 p.m. EDT Wednesday, June 22, 2005 Testimony Before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States
Statement of Kathleen King Director, Health Care GAO-05-850T June 22, 2005 ... |
| Date Feb. 4, 2005 |
Report No. GAO-05-102 |
Title
United States Government Accountability Office GAO
February 2005 Report to Congressional Requesters MEDICAID DRUG REBATE PROGRAM Inadequate Oversight Raises Concerns about Rebates Paid to States GAO-05-102 February 2005 MEDICAID DRUG REBATE PROGRAM Highlights
Highlights of GAO-05-102, a report to congressional requesters Accountability Integrity Reliability Inadequate Oversight Raises Concerns abo... |
